Compare ACP & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ACP | NIE |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 712.7M | 718.5M |
| IPO Year | N/A | N/A |
| Metric | ACP | NIE |
|---|---|---|
| Price | $5.40 | $24.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 337.9K | 70.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 17.79% | 9.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.55 | $18.61 |
| 52 Week High | $7.17 | $22.47 |
| Indicator | ACP | NIE |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 38.02 |
| Support Level | $5.37 | $25.43 |
| Resistance Level | $5.48 | $25.75 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 52.72 | 6.00 |
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.